Synthesis and Characterization of 15N5-Labeled Aflatoxin B1–Formamidopyrimidines and Aflatoxin B1–N7-Guanine from a Partial Double-Stranded Oligodeoxynucleotide as Internal Standards for Mass Spectrometric Measurements

Aflatoxin B1 (AFB1) exposure through contaminated food is a primary contributor to hepatocellular carcinogenesis worldwide. Hepatitis B viral infections in livers dramatically increase the carcinogenic potency of AFB1 exposures. Liver cytochrome P450 oxidizes AFB1 to the epoxide, which in turn reacts with N7-guanine in DNA, producing the cationic trans-8,9-dihydro-8-(N7-guanyl)–9-hydroxyaflatoxin B1 adduct (AFB1–N7-Gua). The opening of the imidazole ring of AFB1–N7-Gua under physiological conditions causes the formation of the cis- and trans-diastereomers of 8,9-dihydro-8-(2,6-diamino-4-oxo-3,4-dihydropyrimid-5-yl-formamido)–9-hydroxyaflatoxin B1 (AFB1–FapyGua). These adducts primarily lead to G → T mutations, with AFB1–FapyGua being significantly more mutagenic than AFB1–N7-Gua. The unequivocal identification and accurate quantification of these AFB1–Gua adducts as biomarkers are essential for a fundamental understanding and prevention of AFB1-induced hepatocellular carcinogenesis. Among a variety of analytical techniques used for this purpose, liquid chromatography–tandem mass spectrometry, with the use of the stable isotope-labeled analogues of AFB1–FapyGua and AFB1–N7-Gua as internal standards, provides the greatest accuracy and sensitivity. cis-AFB1–FapyGua-15N5, trans-AFB1–FapyGua-15N5, and AFB1–N7-Gua-15N5 have been synthesized and used successfully as internal standards. However, the availability of these standards from either academic institutions or commercial sources ceased to exist. Thus, quantitative genomic data regarding AFB1-induced DNA damage in animal models and humans remain challenging to obtain. Previously, AFB1–N7-Gua-15N5 was prepared by reacting AFB1-exo-8,9-epoxide with the uniformly 15N5-labeled DNA isolated from algae grown in a pure 15N-environment, followed by alkali treatment, resulting in the conversion of AFB1–N7-Gua-15N5 to AFB1–FapyGua-15N5. In the present work, we used a different and simpler approach to synthesize cis-AFB1–FapyGua-15N5, trans-AFB1–FapyGua-15N5, and AFB1–N7-Gua-15N5 from a partial double-stranded 11-mer Gua-15N5-labeled oligodeoxynucleotide, followed by isolation and purification. We also show the validation of these 15N5-labeled standards for the measurement of cis-AFB1–FapyGua, trans-AFB1–FapyGua, and AFB1–N7-Gua in DNA of livers of AFB1-treated mice.

[1]  I. Minko,et al.  DNA Sequence Modulates the Efficiency of NEIL1-Catalyzed Excision of the Aflatoxin B1-Induced Formamidopyrimidine Guanine Adduct. , 2021, Chemical research in toxicology.

[2]  J. Essigmann,et al.  Chapter 25. Mutational Spectra Provide Insight into the Mechanisms Bridging DNA Damage to Genetic Disease , 2020 .

[3]  M. Egli,et al.  Recognition of DNA adducts by edited and unedited forms of DNA glycosylase NEIL1. , 2019, DNA repair.

[4]  M. Egli,et al.  Characterization of rare NEIL1 variants found in East Asian populations. , 2019, DNA repair.

[5]  R. Lloyd,et al.  Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis. , 2019, DNA repair.

[6]  R. Lloyd,et al.  Aflatoxin-Guanine DNA Adducts and Oxidatively Induced DNA Damage in Aflatoxin-Treated Mice in Vivo as Measured by Liquid Chromatography-Tandem Mass Spectrometry with Isotope Dilution. , 2018, Chemical research in toxicology.

[7]  J. Essigmann,et al.  Impact of DNA lesion repair, replication and formation on the mutational spectra of environmental carcinogens: Aflatoxin B1 as a case study. , 2018, DNA repair.

[8]  C. Marsden,et al.  The NEIL1 G83D germline DNA glycosylase variant induces genomic instability and cellular transformation , 2017, Oncotarget.

[9]  J. Essigmann,et al.  NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in mice , 2017, Proceedings of the National Academy of Sciences.

[10]  M. Dizdaroglu,et al.  Repair of oxidatively induced DNA damage by DNA glycosylases: Mechanisms of action, substrate specificities and excision kinetics. , 2017, Mutation research.

[11]  Ruidan Ma,et al.  DNA Sequence Modulates Geometrical Isomerism of the trans-8,9-Dihydro-8-(2,6-diamino-4-oxo-3,4-dihydropyrimid-5-yl-formamido)-9-hydroxy Aflatoxin B1 Adduct , 2015, Chemical research in toxicology.

[12]  R. Lloyd,et al.  Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct. , 2014, Carcinogenesis.

[13]  R. Lloyd,et al.  Error-prone Replication Bypass of the Primary Aflatoxin B1 DNA Adduct, AFB1-N7-Gua* , 2014, The Journal of Biological Chemistry.

[14]  J. Groopman,et al.  Public health impacts of foodborne mycotoxins. , 2014, Annual review of food science and technology.

[15]  S. Doublié,et al.  Genome and cancer single nucleotide polymorphisms of the human NEIL1 DNA glycosylase: activity, structure, and the effect of editing. , 2014, DNA repair.

[16]  M. Kew Aflatoxins as a cause of hepatocellular carcinoma. , 2013, Journal of gastrointestinal and liver diseases : JGLD.

[17]  B. Jelaković,et al.  Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry. , 2013, Analytical chemistry.

[18]  J. Groopman,et al.  Food Safety: Mycotoxins – Occurrence and Toxic Effects , 2013 .

[19]  J. Groopman,et al.  Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review , 2012, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[20]  J. Groopman,et al.  Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  D. V. van Thiel,et al.  Non-Viral Causes of Hepatocellular Carcinoma , 2010, Journal of gastrointestinal cancer.

[22]  W. Blonski,et al.  Non-viral causes of hepatocellular carcinoma. , 2010, World journal of gastroenterology.

[23]  M. Voehler,et al.  Structural Perturbations Induced by the α-Anomer of the Aflatoxin B1 Formamidopyrimidine Adduct in Duplex and Single-Strand DNA , 2009, Journal of the American Chemical Society.

[24]  R. Lloyd,et al.  Human Polymorphic Variants of the NEIL1 DNA Glycosylase* , 2007, Journal of Biological Chemistry.

[25]  M. Voehler,et al.  Unraveling the aflatoxin-FAPY conundrum: structural basis for differential replicative processing of isomeric forms of the formamidopyrimidine-type DNA adduct of aflatoxin B1. , 2006, Journal of the American Chemical Society.

[26]  J. Groopman,et al.  Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry. , 2006, Chemical research in toxicology.

[27]  J. Brockmöller,et al.  Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1. , 2006, Chemical research in toxicology.

[28]  J. Groopman,et al.  Role of metabolism and viruses in aflatoxin-induced liver cancer. , 2005, Toxicology and applied pharmacology.

[29]  J. Groopman,et al.  Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk. , 2005, Cancer biomarkers : section A of Disease markers.

[30]  C. Rizzo,et al.  Site-specific synthesis and properties of oligonucleotides containing C8-deoxyguanosine adducts of the dietary mutagen IQ. , 2004, Journal of the American Chemical Society.

[31]  J. Essigmann,et al.  Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo. , 2004, Carcinogenesis.

[32]  T. Massey,et al.  Biotransformation of aflatoxin B x in human lung , 2004 .

[33]  M. Kew Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[34]  J. Essigmann,et al.  The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Mitra,et al.  Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Essigmann,et al.  The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Groopman,et al.  Liquid chromatography electrospray-mass spectrometry of urinary aflatoxin biomarkers: characterization and application to dosimetry and chemoprevention in rats. , 2001, Chemical research in toxicology.

[38]  J. Essigmann,et al.  The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. , 2001, Carcinogenesis.

[39]  G. B. Smith,et al.  Mechanisms of aflatoxin B1 lung tumorigenesis. , 2000, Experimental lung research.

[40]  A. Muñoz,et al.  Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. , 1999, Journal of the National Cancer Institute.

[41]  Fang Wang,et al.  An intercalated and thermally stable FAPY adduct of aflatoxin B1 in a DNA duplex: structural refinement from 1H NMR. , 1998, Biochemistry.

[42]  T. Massey,et al.  Biotransformation of aflatoxin B1 in human lung. , 1996, Carcinogenesis.

[43]  R. Maronpot,et al.  Activation of K-ras in aflatoxin B1-induced lung tumors from AC3F1 (A/J x C3H/HeJ) mice. , 1996, Carcinogenesis.

[44]  S. Griffin DNA damage, DNA repair and disease , 1996, Current Biology.

[45]  J. Essigmann,et al.  Mutational properties of the primary aflatoxin B1-DNA adduct. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Groopman,et al.  Repair of aflatoxin B1 DNA adducts by the UvrABC endonuclease of Escherichia coli. , 1993, The Journal of biological chemistry.

[47]  C. Wild,et al.  Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. , 1993, Environmental health perspectives.

[48]  H. Whittle,et al.  Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[49]  J. Groopman,et al.  Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. , 1992, Cancer research.

[50]  K. Raney,et al.  Preparation of the 8,9-epoxide of the mycotoxin aflatoxin B1: the ultimate carcinogenic species , 1988 .

[51]  J. Gauss,et al.  Spectral and Chemical Properties of Dimethyldioxirane as Determined by Experiment and ab Initio Calculations. , 1988 .

[52]  J. Gauss,et al.  Spectral and chemical properties of dimethyldioxirane as determined by experiment and ab initio calculations , 1987 .

[53]  V. L. Wilson,et al.  Measurement of aflatoxin B1, its metabolites, and DNA adducts by synchronous fluorescence spectrophotometry. , 1986, Cancer research.

[54]  J. Groopman,et al.  Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. J. Shepherd,et al.  An investigation of HPLC post-column iodination conditions for the enhancement of aflatoxin B1 fluorescence. , 1984, Food additives and contaminants.

[56]  C. Chetsanga,et al.  Excision of aflatoxin B1-imidazole ring opened guanine adducts from DNA by formamidopyrimidine-DNA glycosylase. , 1983, Carcinogenesis.

[57]  J. Essigmann,et al.  Interactions of aflatoxin B1 and alkylating agents with DNA: structural and functional studies. , 1983, Cold Spring Harbor symposia on quantitative biology.

[58]  R. C. Garner,et al.  Characterisation of the imidazole ring-opened forms of trans-8,9-di-hydro-8-(7-guanyl)9-hydroxy aflatoxin B1 , 1982 .

[59]  J. Groopman,et al.  In vitro reactions of aflatoxin B1-adducted DNA. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[60]  G. Wogan,et al.  Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. , 1981, Cancer research.

[61]  J. Essigmann,et al.  Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R. C. Garner,et al.  Aflatoxin B-oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids , 1977, Nature.

[63]  J. Essigmann,et al.  Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[64]  G. Wogan,et al.  Structure-activity relationships in toxicity and carcinogenicity of aflatoxins and analogs. , 1971, Cancer research.

[65]  R. Sinnhuber,et al.  Aflatoxin structure and hepatocarcinogenicity in rainbow trout (Salmo gairdneri). , 1971, Journal of the National Cancer Institute.